Review



nonlinear mixed effects modelling software nonmem 7.5  (ICON Clinical Research)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    ICON Clinical Research nonlinear mixed effects modelling software nonmem 7.5
    Nonlinear Mixed Effects Modelling Software Nonmem 7.5, supplied by ICON Clinical Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonlinear+mixed-effect+modeling+methods/nonlinear+mixed+effects+modeling+software+nonmem/pmc12141017-134-17-10
    Average 90 stars, based on 1 article reviews
    nonlinear mixed effects modelling software nonmem 7.5 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: A Repeated Time-to-Positive Symptoms Improvement among Malaysian Patients with Schizophrenia Spectrum Disorders Treated with Clozapine
    Article Snippet: The model structure and its parameters were estimated using the Laplace estimation method through the nonlinear mixed-effect modeling software, NONMEM 7.3.0, (ICON Clinical Research LLC, Ellicott City, MD, USA) [ ].

    Article Title: Predicting Antibiotic Effect of Vancomycin Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation: Dense Sampling versus Sparse Sampling
    Article Snippet: Each dataset was estimated using a first-order conditional estimation with an interaction method in a nonlinear mixed-effects modeling software (NONMEM ® 7.5, ICON Clinical Research LLC, North Wales, PA, USA).

    Article Title: Population pharmacokinetics of oral fosfomycin calcium in healthy women
    Article Snippet: Twenty-four healthy women were included in the study, and plasma samples were collected at different times over a period of 24 h. The concentration–time data of fosfomycin in plasma were modelled by a population approach using a nonlinear mixed-effects modelling implemented by NONMEM 7.4 (ICON Clinical Research LLC, North Wales, PA, USA).

    Article Title: Population Pharmacokinetics and Monte Carlo Simulation of Cefepime in Critically Ill Patients with Hospital-Acquired/Ventilator-Associated Pneumonia
    Article Snippet: Population PK analysis was conducted using nonlinear mixed-effects modeling software (version 7.5, NONMEM®, ICON Clinical Research LLC, North Wales, PA, USA).

    Article Title: Population pharmacokinetic analysis of intravenous voriconazole in cancer patients.
    Article Snippet: The population pharmacokinetic (popPK) modeling process was initiated with the Non-Linear Mixed Effect Modeling (NONMEM) software, version 7.4.4 (Icon Clinical Research LLC, New York, USA) which is supported by the PsN toolkit.

    Article Title: Comparative pharmacokinetics of valproic acid among Pakistani and South Korean patients: A population pharmacokinetic study
    Article Snippet: The actual process of popPK modelling was started by using Non-Linear Mixed Effect Modelling NONMEM® software version 7.4.4 (provided by Icon clinical research LLC New York, USA) with the aid of PsN toolkit [ ].

    Software:

    Article Title: Pharmacokinetic and pharmacodynamic analyses of nafamostat in ECMO patients: comparing central vein and ECMO machine samples
    Article Snippet: .. Nonlinear mixed effects modelling software (NONMEM ® , version 7.5, ICON Clinical Research LLC, North Wales, PA, United States) was used for population PK/PD analysis. ..



    Similar Products

    90
    ICON plc nonlinear mixed-effects modeling method by nonmem version 7.5.0
    Nonlinear Mixed Effects Modeling Method By Nonmem Version 7.5.0, supplied by ICON plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonlinear+mixed-effect+modeling+methods/nonlinear+mixed+effects+modeling+software+nonmem+version+7+4+4/pm35461968-142-15-22
    Average 90 stars, based on 1 article reviews
    nonlinear mixed-effects modeling method by nonmem version 7.5.0 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Kinetica Inc nonlinear mixed-effects modeling method
    Vancomycin PPK model studies in adult patients by the nonlinear <t> mixed-effects modeling </t> method.
    Nonlinear Mixed Effects Modeling Method, supplied by Kinetica Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonlinear+mixed-effect+modeling+methods/nonlinear+mixed+effects+modeling+method/pmc07846798-140-31-35
    Average 90 stars, based on 1 article reviews
    nonlinear mixed-effects modeling method - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    SAS institute nonlinear mixed-effect modeling methods
    Vancomycin PPK model studies in adult patients by the nonlinear <t> mixed-effects modeling </t> method.
    Nonlinear Mixed Effect Modeling Methods, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonlinear+mixed-effect+modeling+methods/nonlinear+mixed+effect+modeling+methods/pmc06972599-146-8-11
    Average 90 stars, based on 1 article reviews
    nonlinear mixed-effect modeling methods - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Vancomycin PPK model studies in adult patients by the nonlinear  mixed-effects modeling  method.

    Journal: Scientific Reports

    Article Title: Population pharmacokinetic modeling and clinical application of vancomycin in Chinese patients hospitalized in intensive care units

    doi: 10.1038/s41598-021-82312-2

    Figure Lengend Snippet: Vancomycin PPK model studies in adult patients by the nonlinear mixed-effects modeling method.

    Article Snippet: Population pharmacokinetic analysis was performed with 993 serum concentrations versus time from 374 adult patients (294 for model building and 80 for external validation, randomly selected by Kinetica), using a nonlinear mixed-effects modeling method with Kinetica.

    Techniques: